Jane Street’s AtriCure ATRC Stock Holding History

Jane Street’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-205,000	Closed	-$6.27M	–	4980
2018 Q4	$6.27M	Buy	+205,000	New	+$6.39M	0.01%	799

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's ATRC Position: Q1 2026 in Review

Jane Street sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 52,620 shares — an estimated $2.08M sold.

Jane Street first reported a position in ATRC in Q2 2020 and held it in 21 quarters. The position peaked at $3.45M in Q3 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Jane Street reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Jane Street sold 52,620 AtriCure shares in Q1 2026, an estimated $2.08M.
Jane Street first reported a position in AtriCure in Q2 2020 and held it in 21 quarters.
Jane Street's AtriCure position peaked at $3.45M in Q3 2025.
223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.